PROCEEDINGS ABSTRACT |
open access
The utility, effectiveness, and challenges of the use of antibody–drug conjugates in targeted cancer therapy: a narrative review
Riyadh A. Yahia*, Dhafir Masheta, Ahmed Hameed AlSaeedi
College of Pharmacy, University of Babylon, Hillah, Iraq (RAY) ▪ Department of Pharmaceutics, College of Pharmacy, University of Babylon, Hillah, Iraq (DM) ▪ College of Pharmacy, University of Hilla, Hillah, Iraq (AHA)
*corresponding author (pha614.riyadh.abdu@student.uobabylon.edu.iq)
Received: 15 April 2026; Revised: 12 June 2026; Accepted: 28 June 2026; Published: 22 July 2026
DOI: 10.5281/zenodo.21486652
Full-text proceedings abstract: PDF
Keywords: antibody–drug conjugates; cancer therapy; monoclonal antibodies; precision medicine; targeted drug delivery
Yahia R. A., Masheta D., AlSaeedi A. H.: The utility, effectiveness, and challenges of the use of antibody–drug conjugates in targeted cancer therapy: a narrative review. Colloq. Erud. 1: 75–76 (2026).
https://doi.org/10.5281/zenodo.21486652
PREVIOUS PROCEEDINGS ABSTRACT ▪ VOLUME 1 (2026) ▪ NEXT PROCEEDINGS ABSTRACT